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Abstract 
Conclusion: Surgery for congenital aural atresia (CAA) is a demanding operation with variable 
anatomical and hearing outcomes. Atresiaplasty operations should be centralized to hospitals with 
large numbers of such patients to ensure sufficient levels of surgical experience. Bone-anchored 
hearing devices or middle-ear implants should be considered as a first line option because they offer 
good hearing predictability. 
Objectives: To evaluate long-term benefits of atresiaplasty on hearing and the impact of surgery on 
quality of life in congenital aural atresia (CAA) patients.  
Methods: We evaluated the long-term hearing results, impact of atresiaplasty on quality of life 
(QoL), the meatal diameter of operated ear canal, and the cumulative number of post-operative 
hospital visits in 14 CAA patients, on average, 12 years (range 4–17 years) post operatively.  
Results: The mean preoperative pure tone average (PTA) was 61 dB HL. The postoperative 
short-term PTA was 36 dB HL and the long-term PTA was 51 dB HL. The mean total Glasgow 
Benefit Inventory (GBI) score was 16 (range -11–39), showing the positive benefit of atresiaplasty 
on QoL. The mean postoperative diameter of the auditory meatus was 6 mm. The average number 
of hospital outpatient visits during the first postoperative year was 10. 
 
 
Introduction 
 
Congenital aural atresia (CAA) comprises a variety of external auditory canal and middle ear 
malformations. In severe cases, the ear canal cannot be detected at all or it may end in a short blind 
pouch, and the ossicles may be absent or anomalous in the middle ear. In milder cases, the ear canal 
is narrower to a variable degree. CAA is often associated with microtia or incomplete development 
of the auricle, and it may cause severe conductive hearing loss [1,2]. The incidence of CAA is 1–
8/20,000 live births, and unilateral cases are 3–7 times more common than bilateral cases [3,4].  
 
Patients with unilateral CAA may experience difficulties in speech discrimination and determining 
the direction of sound. However, most of these patients do not want or need any hearing rehabilitation. 
The surgical options for hearing rehabilitation are bone-anchored hearing devices, middle ear 
implants, and atresiaplasty.  
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Reconstruction of the external ear canal, tympanic membrane, and functional middle ear system is 
one of the most challenging otological operations due to the increased risk of facial nerve damage 
and minor postoperative complications. Narrowing of the reconstructed external ear canal, 
development of recalcitrant granulation tissue, and lateralization of the tympanic membrane are some 
of the common causes leading to poor results after atresiaplasty [5–8]. 
 
In this study, we assess the long-term postoperative outcome (hearing results, surgical success rate, 
and quality of life) of atresiaplasty in patients with CAA.  
   
Materials and Methods 
 
The study design was approved by the ethical review board of Pirkanmaa hospital district (Tampere 
University Hospital, Tampere, Finland), and informed consent was obtained from all participants. 
Using the codes 7440X (ICD9) and Q16.1 (ICD10) as search criteria, a total of 125 CAA patients 
were found. Twenty-two out of 125 patients had had atresiaplasty, and they were invited to participate 
in the study. Fourteen of the 22 patients (15 ears, 9 males/5 females, mean age 22 years, range 8–53 
years) with 13 unilateral and one with bilateral CAA replied and were included. The average 
follow-up time was 12 years (range 4–17 years). All operations had been performed at Tampere 
University Hospital between 1997 and 2011 by two experienced, senior otologic surgeons. 
 
The patients’ medical records showed that preoperatively eight ears had total atresia, four ears had 
partial atresia, and three ears had a stenotic ear canal based on Altmann’s classification [9]. In this 
classification, total atresia is defined as the absence of the entire ear canal. In partial atresia, the ear 
canal ends in a bony barrier, and in a stenotic ear, the ear canal is narrow and the tympanic membrane 
is small in most cases. In addition, 10 patients had microtia, and one patient had mild congenital facial 
nerve weakness. Preoperative high-resolution computed tomography (HRCT) revealed exceptionally 
small or deformed ossicles in 8 out of 15 ears. No inner ear or cochlear nerve malformations were 
detected. 
 
All operated ears were examined and the patients’ quality of life (QoL) was evaluated. The status of 
the reconstructed ear canal was documented and its diameter was measured from the opening of the 
bony ear canal using an ear funnel as a gauge. The QoL was measured using the Glasgow Benefit 
Inventory (GBI) [10]. The GBI scores depict the positive or negative impact of the atresiaplasty on 
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the patient’s QoL. The test contains 18 questions and the response to each question is placed on a 
five-point scale ranging from a large deterioration to a large improvement in health status. The GBI 
consists of a total score and three subscores (general, social support, and physical health). The total 
score is transposed onto a benefit scale ranging from –100 (maximal negative benefit), through 0 (no 
benefit), to +100 (maximal positive benefit). Hearing was measured in a soundproof booth using pure 
tones, and the pure-tone average (PTA, the mean of 0.5, 1, 2, and 4 kHz) was calculated. The 
short-term (2–17-month) postoperative PTA was gathered from the patients’ records.  
 
Results 
 
The mean preoperative PTA was 61 dB HL (range 31–83 dB HL) and the mean air-bone gap (ABG) 
was 51 dB HL (range 31–64 dB HL). The preoperative PTA was 56 dB HL in stenotic ears, 57 dB 
HL in ears with partial atresia, and 65 dB HL in ears with total atresia. The ABGs were 49 dB HL, 
46 dB HL, and 56 dB HL, respectively.  
 
The mean short-term postoperative PTA was 49 dB HL in patients with stenotic ears, 36 dB HL in 
patients with partial atresia, and 32 dB HL in patients with total atresia, while the mean short-term 
postoperative ABGs were 33 dB HL, 28 dB HL, and 28 dB HL, respectively. The corresponding 
mean long-term PTAs were 45 dB HL, 48 dB HL, and 54 dB HL, respectively, while the mean long-
term postoperative ABGs were 32 dB HL, 26 dB HL, and 44 dB HL, respectively. In the long-term 
follow-up, less than 30 dB HL ABG was achieved in two stenotic ears, in three ears with partial 
atresia, and in no ears with total atresia. Ossicles were mobilized in 9 cases and in one case the deform 
ossicles were reconstructed by bone cement. In these cases the mean short-term PTA was 29 dB HL 
and the mean ABG was 24 dB HL and the mean long-term PTA was 45 dB HL and the mean ABG 
was 34 dB HL. In 5 cases ossicles were determined as mobile and no reconstruction were done. In 
this group the mean short-term PTA was 47 dB HL and the mean ABG was 40 dB HL and 
corresponding the mean long-term PTA was 60 dB HL and the mean ABG was 41 dB HL. Tympanic 
membrane was created in 14/15 cases. 
No major intraoperative complications were noted, including sensorineural hearing loss or facial 
nerve damage. In two cases the temporomandibular joint became exposed, but these didn’t cause any 
harm to the patients in long-term follow-up. In long-term follow-up excessive adhesive re-stenosis 
was noted in 6/15 ears, where 5 out of 6 cases were in total atresia group. 
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Postoperative hearing rehabilitation was recommended to six out of 14 patients. A bone-anchored 
hearing device was offered to five patients, but finally only one patient received a Cochlear™ 
BAHA®, while another patient received a MED EL™ Bonebridge®. A hearing aid was fitted for one 
patient. For unknown reasons, hearing rehabilitation was not offered to six patients, although their 
mean PTA was 46 dB HL (range 34–75 dB HL). In two patients with a PTA less than 30 dB HL, 
hearing rehabilitation was not needed.  
 
The mean postoperative diameter of the auditory canal was 6 mm (range 0–11 mm). Better results 
were achieved in stenotic ears (mean 7.5 mm) than in ears with partial (mean 5.5 mm) or total atresia 
(mean 6.0 mm). There wasn’t any correlation between the follow-up time and the diameter of the ear 
canal. 
  
The average number of hospital admissions during the first postoperative year was 10 (range 5–17) 
per patient. At the end of the follow-up, the cumulative number of visits was 21 (range 7–39). The 
number of control visits depends on the tendency for re-stenosis, granulation tissue overgrowth, and 
infections. Excessive adhesive re-stenosis led to revision surgeries in four of the 14 patients, all in 
ears with total atresia. In two cases cartilage part meatal stenosis lead to the revision surgery. 
 
The mean total GBI score showed the positive benefit of atresiaplasty in 13 out of 14 patients, Figure 
1. The GBI score increased as a function of the severity of the CAA and was 4 in patients with a 
stenotic ear, 18 in patients with partial atresia, and 21 in patients with total atresia.  
 
 
Discussion 
 
Previous studies have reported good long-term hearing results after CAA surgery. Chang et al. (2006) 
reviewed the results of 100 operated ears with a mean follow-up time of 57 months. Some 64% of 
their patients achieved an ABG of 30 dB HL or less, which is superior to our results (33%) [7]. Even 
better long-term (over 12 months) hearing results were seen in Digoy’s (2007) study, in which 10 out 
of 13 patients (74%) had a postoperative ABG of 30 dB HL or less. Moreover, in 12 patients, the 
mean postoperative PTA was 18 dB HL better than preoperatively [6]. Edfeldt et al. (2015) reported 
that over 80% of their 100 atresia patients obtained an ABG less than 30 dB HL. Nadaraja et al (2013) 
performed a systematic review to compare the hearing results of atresia surgery and osseointegrated 
bone conduction device in CAA patients [11]. 11 of 35 atresiaplasty studies evalueted PTA less than 
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30 dB as a successful result and it was obtained in 60 % of 390 ears. The mean short-term hearing 
gain in all atresiaplasty patients was 24 dB, whereas osseointegrated bone conduction device short-
term hearing gain was 38 dB. Deterioration of the hearing outcome in CAA patients within time was 
seen. In our study, only three patients (21%) – those with a stenotic ear canal – had a postoperative 
PTA of 30 dB HL or less – i.e. a result that could be considered successful [12].  
 
Our results suggest that less severe CAA associates with better long-term hearing results. 
Surprisingly, our short-term hearing results did not correlate with atresia severity. The mobilization 
of the ossicles either by laser or by diamond drill seems to lead better hearing results in short-term 
(mean PTA 29 vs 47 dB HL) and long-term follow-up (mean PTA 45 vs 60 dB HL). The slow 
postoperative tissue regrowth leading to meatal narrowing seems to be more likely in total atresia, 
which partly explains poorer long-term hearing results in these patients. In stenotic ear canals, the 
operation is smaller and the original canal skin can, in most cases, be left intact to prevent potential 
postoperative stenosis. Revision surgery was performed on four patients, but the surgery did not lead 
to improved hearing in any of the patients. The major problems with most of the ears in the long-term 
follow-up were narrowing of the medial ear canal and thick adhesion on the level of the tympanic 
membrane. The diameter of the bony ear canal normally varies 6–9 mm. In our series, the mean 
diameter of the bony ear canal was close to normal, at 6.0 mm. 
 
The poor hearing results in our study may partly be explained by inexperience. Finland has a small 
population and therefore CAA operations are very rare. There are only 3–20 new CAA cases per year 
in the whole country. Between 1997 and 2011, an average of two atresiaplasties per year were 
performed at our hospital. Taking into account that not all CAA patients are candidates for surgical 
treatment because of anatomical or patient-related reasons, the centralization of all operations in 
Finland would still not lead to even one surgeon gaining sufficient experience to improve efficacy. 
Therefore, there is a case to be made for multinational cooperation to bring all Nordic CAA operations 
to one hospital with a specialization in this surgery. This would guarantee more operations for 
surgeons and theoretically lead to better results. 
 
Many patients required numerous control visits during the first postoperative year, some even for a 
longer period. Revision operations were also performed. Despite the disappointing hearing results, 
all but one patient reported a positive impact of the surgery on QoL. However, relatively low positive 
scores in all GBI subgroups indicate that the surgery had only a minor impact on the QoL, regardless 
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of the preoperative state. Despite the results, the majority of the patients reported that they would go 
through the surgical treatment again. None of the patients claimed that the surgery caused any harm. 
 
The importance of binaural hearing is emphasized in noisy backgrounds and in determining the 
direction of sounds. Bone-anchored hearing devices and middle ear implants are an alternative to 
CAA surgery. Different kinds of devices transmitting the kinetic energy of the sound to the inner ear 
are available. Some devices require an external abutment through the skin to connect the 
bone-anchored device to the audioprocessor, but in the latest generation of the devices, this has been 
replaced by a transcutaneous magnet system. Despite potential skin problems [13–15] and aesthetic 
issues, the hearing results are predictable and in most cases stable over time. In conductive hearing 
loss, hearing results improve with bone-anchored hearing devices from 20 to 35 dB HL, with the 
results being better with percutaneous devices and worse with passive transcutaneous magnet devices 
[16–19]. In our study, despite the modest postoperative hearing results, only a few patients were 
offered other rehabilitation options. Bone-anchored hearing devices, middle ear implants, and hearing 
aids should be actively presented to all CAA patients with insufficient hearing results. 
 
Conclusion 
 
This study reports on the surgical outcome of CAA. Our institution long-term hearing results were 
poor, only 21 % had a postoperative PTA of 30 dB HL or less. Based on our results, we recommend 
the centralization of CAA surgery to countries with a sufficiently large population and number of 
CAA patients that would guarantee the adequate experience level of the surgeon. Bone-anchored 
hearing devices and middle ear implants should be considered as a first-line hearing rehabilitation 
mode in CAA in areas without an experienced atresia surgeon, and they should be actively offered to 
those with suboptimal hearing postoperatively. 
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Legend to the Figure 
 
Figure 1: Glasgow Benefit Inventory (GBI) total scores in congenital aural atresia patients. The 
total score is ranging from –100 (maximal negative benefit), through 0 (no benefit), to +100 
(maximal positive benefit). Number 1 represents stenotic ear canal, number 2 partial atresia and 
number 3 total atresia.  
 
 
 
Table 1. Postoperative results.   Stenosis n=3 Partial atresia n=4 Total atresia n=8 Male 2 2 6 
9  Female 1 2 2 Mean age, years (range) 25 (15-43) 19 (10-34) 22 (8-53) Follow-up time, years (range) 9 (4-12) 14 (12-17) 12 (8-17) Microtia 2 1 7 Mean preoperative PTA, dB HL 56 57 65 Mean short-term PTA, dB HL 49 36 32 Mean long-term PTA, dB HL 45 48 54 Diameter of auditory canal, mm 7.3 5.5 6.0 Postoperative hospital admissions    First year* 8 8 12 Total** 9 14 28 Total GBI score 4 18 21 Revision surgery 0 0 4  
*Data not available in one patient 
**Data not available in two patients 
PTA: Pure tone average; GBI: Glasgow Benefit Inventory 
 
